Research News and Research

RSS

Two Canadian health researchers earn UBC recognition

Two of Canada's most eminent health researchers - Dr. Jacques Genest at McGill University and Dr. Michael Hayden at the University of British Columbia - have been awarded the inaugural Margolese National Brain and Heart Disorders Prizes, the most lucrative prizes bestowed by UBC.

22 Apr 2011

USPTO issues patent to Oragenics ProBiora3 for oral care

Florida-based biopharmaceutical company Oragenics, Inc. announced today the issuance of patent number 7931892 from the United States Patent and Trademark office for ProBiora3, a proprietary blend of naturally occurring oral bacteria shown to produce a wide range of oral care benefits.

22 Apr 2011

Contraception drospirenone raises risk for blood clots

Two new drug safety studies conducted by researchers at Boston University School of Medicine (BUSM) provide strong evidence that women taking oral contraception with drospirenone have an increased risk of nonfatal venous thromboembolism, or blood clots, compared to women taking oral contraception with levonorgestrel.

21 Apr 2011

Survey: Fewer U.S. seniors dying in hospitals

Meanwhile, The Seattle Times reports on an effort in Washington state to "clamp down" on unregulated elder-care referral businesses that promise to help families make arrangements for long-term care for aging relatives.

21 Apr 2011

Nearly 50% of children with autism elope

Today, the Interactive Autism Network (IAN), www.ianproject.org, the nation's largest online autism research project, reveals the preliminary results of the first major survey on wandering and elopement among individuals with autism spectrum disorders (ASD), and announces the launch of a new research survey on the association between pregnancy factors and ASD.

21 Apr 2011

Nature solves complex topological puzzles in DNA substrate recognition with elegant simplicity

A major discovery about an enzyme's structure has opened a window on understanding DNA repair. Scientists at Duke University Medical Center have determined the structure of a nuclease that will help scientists to understand several DNA repair pathways, a welcome development for cancer research.

21 Apr 2011

Discovery of cancer drugs to kill malaria parasite could open up new strategies for treatment

Ahead of World Malaria Day (25 April), EU-funded researchers have discovered that drugs originally designed to inhibit the growth of cancer cells can also kill the parasite that causes malaria. They believe this discovery could open up a new strategy for combating this deadly disease, which, according to World Health Organisation statistics, infected around 225 million and killed nearly 800 000 people worldwide in 2009.

21 Apr 2011

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.

21 Apr 2011

Utah philanthropists gift Huntsman Cancer Institute $41 million for cancer research

Officials at Huntsman Cancer Institute (HCI) at the University of Utah today announced a gift of $41 million from Utah philanthropists Jon and Karen Huntsman.

21 Apr 2011

University of Freiburg launches new science portal, Surprising Science

The University of Freiburg is extending its communicative bounds with a brand new science portal, Surprising Science. Starting today, the university will regularly present exciting new research findings at www.surprising-science.de, some of them in multimedia form. The site will also provide comprehensive background information and news from daily life at the university.

21 Apr 2011

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Merck and Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today the initiation of a Phase III clinical program to evaluate the safety and immunogenicity of an investigational pediatric hexavalent combination vaccine.

21 Apr 2011

Toddlers having insecure emotional relationship with mothers at increased risk for obesity

Toddlers who do not have a secure emotional relationship with their parents, and particularly their mothers, could be at increased risk for obesity by age 4 ½, according to new research.

21 Apr 2011

Repligen anticipates 30% increase in total revenues for 2011

Repligen Corporation today announced preliminary financial results for fiscal year 2011 which ended March 31, 2011. Total revenue for the year is expected to be $27.3 million compared to $21.0 million in the prior fiscal year, an increase of 30%.

21 Apr 2011

First Spouses support Down syndrome cognitive research

New Jersey Governor First Spouse Mary Pat Christie was joined by several other First Spouses from across the country in sponsoring the "Light the Way" event on March 21, 2011 to increase awareness of, and encourage support for, the rapidly advancing area of Down syndrome cognitive research.

21 Apr 2011